Tapiwa Mbengeranwa
Overview
Explore the profile of Tapiwa Mbengeranwa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
64
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mbengeranwa T, Ziemba L, Brummel S, Johnston B, Cassim H, Theron G, et al.
J Acquir Immune Defic Syndr
. 2025 Feb;
PMID: 40001275
Background: The impact on infant bone, growth, and renal health of in utero and breastmilk exposure to contemporary antiretroviral treatment (ART) remains unclear. Methods: 643 pregnant women with HIV in...
2.
Markers of Maternal Bone and Renal Toxicity Through 50 Weeks Postpartum: IMPAACT 2010 (VESTED) Trial
Masheto G, Brummel S, Ziemba L, Shepherd J, Mbengeranwa T, Igawa L, et al.
J Acquir Immune Defic Syndr
. 2024 Sep;
97(2):172-179.
PMID: 39250651
Background: Safety data from randomized trials of antiretrovirals in pregnancy are scarce. We evaluated maternal bone and renal data from the International Maternal Pediatric Adolescent AIDS Clinical Trials Network 2010...
3.
Eke A, Brummel S, Aliyu M, Stranix-Chibanda L, Eleje G, Ezebialu I, et al.
Clin Infect Dis
. 2024 Sep;
PMID: 39219495
Objective: Tenofovir alafenamide (TAF)-based antiretroviral therapy (ART) regimens have been associated with adverse changes in lipid and glucose profiles compared with tenofovir disoproxil fumarate (TDF)-based ART, but data in pregnancy...
4.
Cherkos A, LaCourse S, Enquobahrie D, Richardson B, Bradford S, Montepiedra G, et al.
EClinicalMedicine
. 2023 Mar;
58:101912.
PMID: 36969345
Background: Isoniazid preventive therapy (IPT) initiation during pregnancy was associated with increased incidence of adverse pregnancy outcomes in the TB APPRISE trial. Effects of IPT exposure on infant growth are...
5.
Stranix-Chibanda L, Tierney C, Pinilla M, George K, Aizire J, Chipoka G, et al.
PLoS One
. 2021 Aug;
16(8):e0255250.
PMID: 34415933
Background: Malnutrition is highly prevalent in HIV-exposed perinatally uninfected infants (HEUs) increasing the risk of morbidity and mortality throughout the life course. We set out to compare the effect of...
6.
Atuhaire P, Brummel S, Mmbaga B, Angelidou K, Fairlie L, Violari A, et al.
PLoS One
. 2020 Jan;
15(1):e0228003.
PMID: 31999753
Background: Given well documented challenges faced by pregnant women living with HIV taking lifetime ART, it is critical to understand the impact of short-term ART exposure followed by treatment interruption...
7.
Cunningham C, McFarland E, Morrison R, Capparelli E, Safrit J, Mofenson L, et al.
J Infect Dis
. 2019 Nov;
222(4):628-636.
PMID: 31681963
Background: Although mother-to-child human immunodeficiency virus (HIV) transmission has dramatically decreased with maternal antiretroviral therapy, breast milk transmission accounts for most of the 180 000 new infant HIV infections annually....
8.
Barlow-Mosha L, Angelidou K, Lindsey J, Archary M, Cotton M, Dittmer S, et al.
Clin Infect Dis
. 2016 Jul;
63(8):1113-1121.
PMID: 27439527
Background: The International Maternal Pediatric Adolescent AIDS Clinical Trials Network (IMPAACT) P1060 study demonstrated short-term superiority of lopinavir/ritonavir (LPV/r) over nevirapine (NVP) in antiretroviral therapy (ART), regardless of prior NVP...